Covid-19: India gets third vaccine, Sputnik V launched at Rs 995/dose

spu1200

DRL is slated start local production of the vaccine in July 2021 and is expected to make 15.6 crore doses in the August-December period. Indian pharma major Dr Reddy’s Laboratories (DRL), which has in-licensed Russia’s Covid-19 vaccine, launched Sputnik V in the domestic market on Friday, by administering the first dose to a person in … Read more

Covid-19: India gets first batch of 1.5 lakh doses of Russia’s Sputnik V vaccine

Sputnik COVID 19 vaccine

India had approved emergency supplies of hydroxychloroquine to Russia when the pandemic unfolded last year. India on Saturday received the first batch of 1,50,000 doses of Russia’s Sputnik V vaccine even as the country is battling a second wave of the Covid-19 pandemic. Three million additional doses of the Russian vaccine are scheduled to arrive … Read more

India to become Russian Sputnik V vaccine’s production hub, to start making 50 mn doses per month by summer

sputnik

India is the most populous country to approve Sputnik V. India’s medicine regulator Drugs Controller General of India has cleared Russia’s Sputnik V vaccine for emergency use in the country. Sputnik V, made by Moscow’s Gamaleya National Research Institute of Epidemiology and Microbiology, has become the third vaccine after Serum institute of India’s Covishield and Bharat … Read more

Sputnik V approved: But can it resolve the COVID19 vaccine supply shortage in India?

sputnikV reuters new

It is not clear at what price the vaccine will be made available in India. (Photo source: Reuters) The much-awaited approval for a third vaccine has happened with the subject expert committee of the Indian drug regulatory authority recommending emergency use authorization (EUA) for the Russian Sputnik V vaccine. This has been hailed by many … Read more

COVID-19 vaccine: Russia’s Sputnik V gets emergency use authorisation in India

sputnikV reuters

In a major development, Sputnik V – a COVID-19 vaccine developed by Russia – has been grated emergency use authorisation in India. It will be rolled in India by Pharma major Dr Reddy’s Laboratories. “Subject Expert Committee approves Dr Reddy’s application for emergency use authorisation to Sputnik V,” news ANI quoted sources as saying. Like … Read more

Building trust in COVID-19 vaccination: Data suggests top 5 vaccine preference among Indians

flu vaccine 3

The survey was conducted among 9 countries including India. Ever since the Coronavirus broke out last year, many have pinned their hopes on vaccine development. However, at a time when vaccines have come, many are skeptical about getting a shot as they do not trust the vaccinations completely or are concerned about side effects. In … Read more

Covid-19 vaccine in India: Decision on emergency use nod to Sputnik V likely today

Sputnik vaccine

The meeting of the Subject Expert Committee of Central Drug Standards Control Organisation is scheduled to be held today to discuss Dr Reddy’s application seeking emergency use approval for Sputnik V vaccine. Covid-19 vaccine India update: The Subject Expert Committee (SEC) of the Central Drug Standards Control Organisation is likely to meet today to take … Read more

Covid-19 vaccine: Dr Reddy’s seeks emergency use approval for Sputnik V; Why it is important for India

Sputnik vaccine

At present, two Coronavirus vaccines are being used in the country namely Covishield and Covaxin, and the entry of another vaccine would further expedite the fight against Coronavirus. Even as the Coronavirus vaccination drive for healthcare and frontline workers in the country is going at full throttle with more than 1 crore beneficiaries so far, … Read more

Covid-19 vaccine in India: Who will bear the cost — the government or people?

covid vaccine 1

Many from the opposition parties are demanding that the Covid-19 vaccine should be distributed free. The race for a Covid-19 vaccine has entered the last lap. Even countries like the UK and then Russia have formally approved Covid-19 vaccine for their countries; the UK has given its nod to the vaccine developed by Pfizer-BioNTech while … Read more

Lupin reports cybersecurity breach, COVID-19 makes pharma firms more vulnerable

covid19

Experts feel that these firms should strengthen their cybersecurity measures. (Photo source: IE) Indian pharmaceutical company Lupin is the latest victim of a cyber attack. The incident has been reported just a fortnight after Dr Reddy’s Laboratories ‘isolated’ its data centre services after being hit by a similar attack. According to a report by The … Read more